April 10-12, 2022
Orlando, Florida
ISPE has a vast pool of talented but unrecognized members; do your part to change this – we want your nominations!
Three awards are open for nominations through January 19, 2022
Learn more here
The European Drug Utilization Research Group (EuroDURG) a subgroup of ISPE's Drug Utilization / Health Services Research SIG, has prepared a statement calling for priority actions and targets in the field of drug utilization and is seeking ISPE endorsement of the statement. Consistent with Section 1.7.1 Endorsement of documents as ISPE Public Policy (see ISPE Policy Manual) the Public Policy Committee has approved a call for member comments for the statement
Deadline: December 12, 2021
To learn more and access the comments paper, click here
ISPE announces that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry. The Real-World Evidence Transparency Initiative is a partnership between ISPE, ISPOR, the Duke-Margolis Center for Health Policy, and the National Pharmaceutical Council. Read more here.
Consider applying to serve on the Board of Directors for terms starting Aug 2022. The ISPE Nominating Committee is seeking candidates for election to the Society's Board of Directors for a 3-year term.
Learn more here
Deadline: 11:00 pm EST Dec 31
The ISPE Board of Directors established the membership category ISPE Fellow to recognize and advance leadership in the Society. This membership category is awarded upon recommendation by a committee of peers. Learn more and apply for an ISPE Fellowship here.
Deadline: 11:00 pm EST Dec 15
View ICPE awards video here
ISPE's SoMe committee manages all ISPE social media accounts. Want something shared or have a suggested post? We'd love to hear from you, submit your ideas to the SoMe committee using this form.
.png)